Multiple Partnerships Help Drive Precision Medicine Trial For Parkinson's, Gilead Prioritizes Women With Its First HIV Cure Trial In Africa, and More
Clinical Leader
A resource and forum to investigate and resolve the common struggles related to running effective clinical trials.
Welcome to the Clinical Trial Insights newsletter, featuring strategic insights and expert opinions on designing and running clinical trials. Each edition covers the latest trending articles on ClinicalLeader.com.
If you like what you're seeing in our condensed LinkedIn editions, subscribe to our daily newsletter for full access to exclusive articles, webinars, e-books, and more! Subscribe Now →
CLINICAL LEADER SOLUTIONS EXPO: PATIENT RECRUITMENT & ENGAGEMENT
05.06 & 05.08
This free digital event connects sponsors with industry leaders and innovators who support every stage of the patient journey. From feasibility and site selection to recruitment, enrollment, and ongoing engagement, experts will share insights, showcase capabilities, and answer your questions in this interactive forum!
TOP 5 READS OF THE PAST WEEK
In this Q&A, Neuron23 CMO Sam Jackson , MD, explains the company’s desire to set a new standard in precision medicine for neurology, backed by well-aligned partnerships and fit-for-purpose digital biomarker solutions.
During 2025, advancements in technology are poised to redefine the traditional randomized controlled trial, enhancing efficiency and data accuracy. This Scrip Asks article compiles insights from 30 thought leaders to explore the anticipated trends shaping clinical trials this year.
Gilead Sciences ’s Head Of HIV Cure Program Strategy Devi SenGupta discusses the challenges and triumphs of a groundbreaking HIV cure trial in South Africa, exploring logistical hurdles, the importance of community trust, and the impact of cultural context on clinical research.
Prepaid debit cards have revolutionized participant payments in clinical trials, however, questions are being raised about transparency and who sets fees. This article aims to clarify these issues, breaking down the realities of prepaid debit card fees and their implications for both participants and the organizations that issue them.
Medical oncologist Frédéric Fiteni , Ph.D. reveals the widespread industry reluctance to study patient quality of life, describes its importance to patient satisfaction, and offers best practices for its integration.
MORE TO EXPLORE
Clinical Leader is an online community serving professionals in the clinical research space. We share insights and best practices — from industry experts — to help sponsors and CROs tackle the biggest challenges they face in designing and running clinical trials.
To get the most out of our offerings, join the Clinical Leader community.
Clinical Leader, It’s inspiring to see how partnerships are pushing the boundaries of precision medicine and focusing on important issues like women's health in clinical trials. It really highlights the need for patient-centered approaches! What do you think will be the biggest change in clinical trials over the next few years? 🤔💡 #ClinicalTrials #PrecisionMedicine